UniProt ID | TACC1_HUMAN | |
---|---|---|
UniProt AC | O75410 | |
Protein Name | Transforming acidic coiled-coil-containing protein 1 | |
Gene Name | TACC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 805 | |
Subcellular Localization |
Cytoplasm . Nucleus . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Midbody . Nucleus during interphase. Weakly concentrated at centrosomes during mitosis and colocalizes with AURKC at the midbody during cytokinesis. Isoform 5 |
|
Protein Description | Likely involved in the processes that promote cell division prior to the formation of differentiated tissues.. | |
Protein Sequence | MAFSPWQILSPVQWAKWTWSAVRGGAAGEDEAGGPEGDPEEEDSQAETKSLSFSSDSEGNFETPEAETPIRSPFKESCDPSLGLAGPGAKSQESQEADEQLVAEVVEKCSSKTCSKPSENEVPQQAIDSHSVKNFREEPEHDFSKISIVRPFSIETKDSTDISAVLGTKAAHGCVTAVSGKALPSSPPDALQDEAMTEGSMGVTLEASAEADLKAGNSCPELVPSRRSKLRKPKPVPLRKKAIGGEFSDTNAAVEGTPLPKASYHFSPEELDENTSPLLGDARFQKSPPDLKETPGTLSSDTNDSGVELGEESRSSPLKLEFDFTEDTGNIEARKALPRKLGRKLGSTLTPKIQKDGISKSAGLEQPTDPVARDGPLSQTSSKPDPSQWESPSFNPFGSHSVLQNSPPLSSEGSYHFDPDNFDESMDPFKPTTTLTSSDFCSPTGNHVNEILESPKKAKSRLITSGCKVKKHETQSLALDACSRDEGAVISQISDISNRDGHATDEEKLASTSCGQKSAGAEVKGEPEEDLEYFECSNVPVSTINHAFSSSEAGIEKETCQKMEEDGSTVLGLLESSAEKAPVSVSCGGESPLDGICLSESDKTAVLTLIREEIITKEIEANEWKKKYEETRQEVLEMRKIVAEYEKTIAQMIEDEQRTSMTSQKSFQQLTMEKEQALADLNSVERSLSDLFRRYENLKGVLEGFKKNEEALKKCAQDYLARVKQEEQRYQALKIHAEEKLDKANEEIAQVRTKAKAESAALHAGLRKEQMKVESLERALQQKNQEIEELTKICDELIAKLGKTD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAFSPWQIL ------CCCCCCCEE | 17.39 | 20068231 | |
2 (in isoform 5) | Myristoylation | - | 17.39 | 25807930 | |
4 | Phosphorylation | ----MAFSPWQILSP ----CCCCCCCEECH | 18.72 | 22199227 | |
4 (in isoform 4) | Phosphorylation | - | 18.72 | 24043423 | |
4 (in isoform 5) | Phosphorylation | - | 18.72 | 24043423 | |
6 (in isoform 4) | Phosphorylation | - | 9.17 | 24043423 | |
6 (in isoform 5) | Phosphorylation | - | 9.17 | 24043423 | |
8 (in isoform 4) | Phosphorylation | - | 3.48 | 22468782 | |
8 (in isoform 5) | Phosphorylation | - | 3.48 | 22468782 | |
10 | Phosphorylation | FSPWQILSPVQWAKW CCCCCEECHHHHHHH | 25.34 | 25159151 | |
20 | Phosphorylation | QWAKWTWSAVRGGAA HHHHHHHHHHCCCCC | 14.98 | 28555341 | |
44 | Phosphorylation | GDPEEEDSQAETKSL CCCHHHCCCCCHHCC | 34.27 | 23401153 | |
48 | Phosphorylation | EEDSQAETKSLSFSS HHCCCCCHHCCCCCC | 29.02 | 22167270 | |
50 | Phosphorylation | DSQAETKSLSFSSDS CCCCCHHCCCCCCCC | 36.34 | 30278072 | |
52 | Phosphorylation | QAETKSLSFSSDSEG CCCHHCCCCCCCCCC | 30.12 | 30278072 | |
54 | Phosphorylation | ETKSLSFSSDSEGNF CHHCCCCCCCCCCCC | 29.84 | 25159151 | |
55 | Phosphorylation | TKSLSFSSDSEGNFE HHCCCCCCCCCCCCC | 43.05 | 30278072 | |
57 | Phosphorylation | SLSFSSDSEGNFETP CCCCCCCCCCCCCCC | 49.72 | 25159151 | |
63 | Phosphorylation | DSEGNFETPEAETPI CCCCCCCCCCCCCCC | 23.45 | 28464451 | |
68 | Phosphorylation | FETPEAETPIRSPFK CCCCCCCCCCCCCCH | 30.94 | 24173317 | |
75 | Methylation | TPIRSPFKESCDPSL CCCCCCCHHHCCCCC | 52.69 | 115980249 | |
75 | Ubiquitination | TPIRSPFKESCDPSL CCCCCCCHHHCCCCC | 52.69 | - | |
81 | Phosphorylation | FKESCDPSLGLAGPG CHHHCCCCCCCCCCC | 23.09 | 17081983 | |
91 | Phosphorylation | LAGPGAKSQESQEAD CCCCCCCCHHCHHHH | 38.35 | 23663014 | |
94 | Phosphorylation | PGAKSQESQEADEQL CCCCCHHCHHHHHHH | 26.19 | 30266825 | |
118 | Phosphorylation | SKTCSKPSENEVPQQ CCCCCCCCCCCCCHH | 57.71 | 25137130 | |
129 | Phosphorylation | VPQQAIDSHSVKNFR CCHHHHHHHCCCCHH | 16.14 | 23403867 | |
131 | Phosphorylation | QQAIDSHSVKNFREE HHHHHHHCCCCHHHC | 38.44 | 26657352 | |
132 (in isoform 8) | Ubiquitination | - | 5.00 | 21906983 | |
144 | Phosphorylation | EEPEHDFSKISIVRP HCCCCCCCCEEEEEC | 34.83 | 25137130 | |
147 | Phosphorylation | EHDFSKISIVRPFSI CCCCCCEEEEECEEE | 20.83 | 25159151 | |
153 | Phosphorylation | ISIVRPFSIETKDST EEEEECEEEECCCCC | 23.38 | 28102081 | |
156 | Phosphorylation | VRPFSIETKDSTDIS EECEEEECCCCCCCH | 38.18 | 23403867 | |
168 | Phosphorylation | DISAVLGTKAAHGCV CCHHHHCCHHHCCCE | 17.22 | 20058876 | |
169 | Ubiquitination | ISAVLGTKAAHGCVT CHHHHCCHHHCCCEE | 41.60 | - | |
179 | Phosphorylation | HGCVTAVSGKALPSS CCCEEEECCCCCCCC | 31.92 | 20058876 | |
218 | Phosphorylation | ADLKAGNSCPELVPS HHHHCCCCCCCCCCC | 30.08 | 26657352 | |
225 | Phosphorylation | SCPELVPSRRSKLRK CCCCCCCCHHHHCCC | 32.61 | 30108239 | |
228 | Phosphorylation | ELVPSRRSKLRKPKP CCCCCHHHHCCCCCC | 34.63 | 21531210 | |
234 | Acetylation | RSKLRKPKPVPLRKK HHHCCCCCCCCCCCC | 62.78 | 12429785 | |
240 | Acetylation | PKPVPLRKKAIGGEF CCCCCCCCCCCCCCC | 54.99 | 12429797 | |
248 | Phosphorylation | KAIGGEFSDTNAAVE CCCCCCCCCCCCCCC | 38.94 | 30266825 | |
250 | Phosphorylation | IGGEFSDTNAAVEGT CCCCCCCCCCCCCCC | 26.09 | 30266825 | |
257 | Phosphorylation | TNAAVEGTPLPKASY CCCCCCCCCCCCCCC | 14.24 | 29255136 | |
263 | Phosphorylation | GTPLPKASYHFSPEE CCCCCCCCCCCCHHH | 25.85 | 19690332 | |
264 | Phosphorylation | TPLPKASYHFSPEEL CCCCCCCCCCCHHHH | 16.25 | 30266825 | |
267 | Phosphorylation | PKASYHFSPEELDEN CCCCCCCCHHHHCCC | 20.35 | 30266825 | |
275 | Phosphorylation | PEELDENTSPLLGDA HHHHCCCCCCCCCCH | 29.67 | 23401153 | |
276 | Phosphorylation | EELDENTSPLLGDAR HHHCCCCCCCCCCHH | 25.73 | 25159151 | |
286 | Ubiquitination | LGDARFQKSPPDLKE CCCHHHCCCCCCHHC | 63.32 | - | |
287 | Phosphorylation | GDARFQKSPPDLKET CCHHHCCCCCCHHCC | 30.77 | 30108239 | |
294 | Phosphorylation | SPPDLKETPGTLSSD CCCCHHCCCCCCCCC | 25.98 | 30624053 | |
297 | Phosphorylation | DLKETPGTLSSDTND CHHCCCCCCCCCCCC | 25.35 | 23403867 | |
299 | Phosphorylation | KETPGTLSSDTNDSG HCCCCCCCCCCCCCC | 26.46 | 23403867 | |
300 | Phosphorylation | ETPGTLSSDTNDSGV CCCCCCCCCCCCCCC | 52.12 | 23403867 | |
302 | Phosphorylation | PGTLSSDTNDSGVEL CCCCCCCCCCCCCCC | 42.76 | 23403867 | |
305 | Phosphorylation | LSSDTNDSGVELGEE CCCCCCCCCCCCCCC | 46.97 | 25159151 | |
313 | Phosphorylation | GVELGEESRSSPLKL CCCCCCCCCCCCEEE | 32.91 | 22199227 | |
315 | Phosphorylation | ELGEESRSSPLKLEF CCCCCCCCCCEEEEE | 45.66 | 30266825 | |
316 | Phosphorylation | LGEESRSSPLKLEFD CCCCCCCCCEEEEEE | 32.89 | 30266825 | |
345 (in isoform 5) | Ubiquitination | - | 6.71 | 21906983 | |
347 | Phosphorylation | KLGRKLGSTLTPKIQ HHHHCCCCCCCHHHC | 30.58 | 23401153 | |
348 | Phosphorylation | LGRKLGSTLTPKIQK HHHCCCCCCCHHHCC | 32.62 | 22199227 | |
350 | Phosphorylation | RKLGSTLTPKIQKDG HCCCCCCCHHHCCCC | 23.71 | 21815630 | |
357 (in isoform 4) | Ubiquitination | - | 32.86 | 21906983 | |
359 | Phosphorylation | KIQKDGISKSAGLEQ HHCCCCCCCCCCCCC | 26.53 | 23312004 | |
360 | Ubiquitination | IQKDGISKSAGLEQP HCCCCCCCCCCCCCC | 42.26 | - | |
361 | Phosphorylation | QKDGISKSAGLEQPT CCCCCCCCCCCCCCC | 22.30 | 30108239 | |
373 (in isoform 6) | Ubiquitination | - | 50.05 | 21906983 | |
381 | Phosphorylation | DGPLSQTSSKPDPSQ CCCCCCCCCCCCHHH | 28.82 | - | |
406 | Phosphorylation | SHSVLQNSPPLSSEG CCHHHCCCCCCCCCC | 18.22 | 22468782 | |
454 | Phosphorylation | HVNEILESPKKAKSR CHHHHHHCHHHHHHH | 38.28 | 25159151 | |
464 | Phosphorylation | KAKSRLITSGCKVKK HHHHHHHCCCCCCCC | 24.53 | 28102081 | |
465 | Phosphorylation | AKSRLITSGCKVKKH HHHHHHCCCCCCCCC | 34.89 | 28102081 | |
468 | Ubiquitination | RLITSGCKVKKHETQ HHHCCCCCCCCCCCC | 61.69 | - | |
471 | Ubiquitination | TSGCKVKKHETQSLA CCCCCCCCCCCCCHH | 50.05 | - | |
474 | Phosphorylation | CKVKKHETQSLALDA CCCCCCCCCCHHHHH | 24.15 | 23312004 | |
476 | Phosphorylation | VKKHETQSLALDACS CCCCCCCCHHHHHCC | 24.03 | 23312004 | |
477 (in isoform 2) | Phosphorylation | - | 3.84 | 28270605 | |
483 | Phosphorylation | SLALDACSRDEGAVI CHHHHHCCCCCCCEE | 44.48 | - | |
491 | Phosphorylation | RDEGAVISQISDISN CCCCCEEEEEHHCCC | 18.18 | 28450419 | |
494 | Phosphorylation | GAVISQISDISNRDG CCEEEEEHHCCCCCC | 22.66 | 28450419 | |
497 | Phosphorylation | ISQISDISNRDGHAT EEEEHHCCCCCCCCC | 30.70 | 30576142 | |
504 | Phosphorylation | SNRDGHATDEEKLAS CCCCCCCCCHHHHHC | 37.96 | 23401153 | |
511 | Phosphorylation | TDEEKLASTSCGQKS CCHHHHHCCCCCCCC | 31.15 | 23927012 | |
512 | Phosphorylation | DEEKLASTSCGQKSA CHHHHHCCCCCCCCC | 23.56 | 23927012 | |
513 | Phosphorylation | EEKLASTSCGQKSAG HHHHHCCCCCCCCCC | 17.47 | 23927012 | |
517 | Ubiquitination | ASTSCGQKSAGAEVK HCCCCCCCCCCCCCC | 27.79 | - | |
518 | Phosphorylation | STSCGQKSAGAEVKG CCCCCCCCCCCCCCC | 24.85 | 26074081 | |
533 | Phosphorylation | EPEEDLEYFECSNVP CCHHHHCCEECCCCC | 16.39 | 28796482 | |
537 | Phosphorylation | DLEYFECSNVPVSTI HHCCEECCCCCHHHH | 33.39 | 28796482 | |
542 | Phosphorylation | ECSNVPVSTINHAFS ECCCCCHHHHHHHCC | 19.94 | 27251275 | |
543 | Phosphorylation | CSNVPVSTINHAFSS CCCCCHHHHHHHCCC | 26.49 | 27251275 | |
549 | Phosphorylation | STINHAFSSSEAGIE HHHHHHCCCCCCCCC | 33.46 | 27251275 | |
550 | Phosphorylation | TINHAFSSSEAGIEK HHHHHCCCCCCCCCH | 26.24 | 27251275 | |
551 | Phosphorylation | INHAFSSSEAGIEKE HHHHCCCCCCCCCHH | 30.21 | 27251275 | |
568 | Phosphorylation | QKMEEDGSTVLGLLE HHHHCCCCHHHHHHH | 27.88 | 22199227 | |
569 | Phosphorylation | KMEEDGSTVLGLLES HHHCCCCHHHHHHHH | 25.86 | 22199227 | |
576 | Phosphorylation | TVLGLLESSAEKAPV HHHHHHHHCCCCCCE | 34.51 | 22199227 | |
577 | Phosphorylation | VLGLLESSAEKAPVS HHHHHHHCCCCCCEE | 30.95 | 22199227 | |
588 (in isoform 3) | Ubiquitination | - | 35.08 | 21906983 | |
591 | Phosphorylation | SVSCGGESPLDGICL EEECCCCCCCCCEEC | 33.75 | 10470851 | |
616 | Phosphorylation | LIREEIITKEIEANE HHHHHHHHHHHHHHH | 28.43 | 24670416 | |
617 | Ubiquitination | IREEIITKEIEANEW HHHHHHHHHHHHHHH | 46.41 | - | |
640 | Acetylation | QEVLEMRKIVAEYEK HHHHHHHHHHHHHHH | 39.98 | 7965395 | |
640 | Ubiquitination | QEVLEMRKIVAEYEK HHHHHHHHHHHHHHH | 39.98 | - | |
647 | Acetylation | KIVAEYEKTIAQMIE HHHHHHHHHHHHHHH | 44.31 | 7965407 | |
647 | Ubiquitination | KIVAEYEKTIAQMIE HHHHHHHHHHHHHHH | 44.31 | - | |
660 | Phosphorylation | IEDEQRTSMTSQKSF HHHHHHHHHHCHHHH | 23.42 | 22468782 | |
665 | Ubiquitination | RTSMTSQKSFQQLTM HHHHHCHHHHHHHHH | 53.67 | - | |
666 | Phosphorylation | TSMTSQKSFQQLTME HHHHCHHHHHHHHHH | 22.20 | 22468782 | |
687 | Phosphorylation | DLNSVERSLSDLFRR HHHHHHHHHHHHHHH | 20.79 | 22468782 | |
689 | Phosphorylation | NSVERSLSDLFRRYE HHHHHHHHHHHHHHH | 33.25 | 22468782 | |
714 | Ubiquitination | KNEEALKKCAQDYLA HCHHHHHHHHHHHHH | 35.34 | - | |
730 | Phosphorylation | VKQEEQRYQALKIHA HHHHHHHHHHHHHHH | 9.61 | 20068231 | |
734 | Ubiquitination | EQRYQALKIHAEEKL HHHHHHHHHHHHHHH | 35.15 | - | |
740 | Acetylation | LKIHAEEKLDKANEE HHHHHHHHHHHHHHH | 54.19 | 25953088 | |
754 | Acetylation | EIAQVRTKAKAESAA HHHHHHHHHHHHHHH | 37.01 | 19824175 | |
756 | Ubiquitination | AQVRTKAKAESAALH HHHHHHHHHHHHHHH | 55.00 | - | |
759 | Phosphorylation | RTKAKAESAALHAGL HHHHHHHHHHHHHHH | 24.57 | - | |
783 | Ubiquitination | LERALQQKNQEIEEL HHHHHHHHHHHHHHH | 47.87 | 2190698 | |
783 (in isoform 1) | Ubiquitination | - | 47.87 | 21906983 | |
792 | Ubiquitination | QEIEELTKICDELIA HHHHHHHHHHHHHHH | 54.70 | - | |
795 (in isoform 2) | Ubiquitination | - | 58.15 | 21906983 | |
800 | Ubiquitination | ICDELIAKLGKTD-- HHHHHHHHHCCCC-- | 51.26 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
228 | S | Phosphorylation | Kinase | AURC | Q9UQB9 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TACC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TACC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
YETS4_HUMAN | YEATS4 | physical | 11903063 | |
AURKB_HUMAN | AURKB | physical | 15064709 | |
AURKA_HUMAN | AURKA | physical | 15064709 | |
LSM7_HUMAN | LSM7 | physical | 14603251 | |
TDRD7_HUMAN | TDRD7 | physical | 14603251 | |
CKAP5_HUMAN | CKAP5 | physical | 14603251 | |
AURKA_HUMAN | AURKA | physical | 14603251 | |
CKAP5_HUMAN | CKAP5 | physical | 11903063 | |
LSM7_HUMAN | LSM7 | physical | 12165861 | |
RUXG_HUMAN | SNRPG | physical | 12165861 | |
BARD1_HUMAN | BARD1 | physical | 19176389 | |
KAT2A_HUMAN | KAT2A | physical | 14767476 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
FBW1A_HUMAN | BTRC | physical | 25416956 | |
MEMO1_HUMAN | MEMO1 | physical | 25416956 | |
SH24A_HUMAN | SH2D4A | physical | 25416956 | |
LYST_HUMAN | LYST | physical | 26496610 | |
BRD3_HUMAN | BRD3 | physical | 26496610 | |
RBCC1_HUMAN | RB1CC1 | physical | 26496610 | |
TACC2_HUMAN | TACC2 | physical | 26496610 | |
BI2L1_HUMAN | BAIAP2L1 | physical | 26496610 | |
TACC2_HUMAN | TACC2 | physical | 28514442 | |
RNF41_HUMAN | RNF41 | physical | 28514442 | |
SKAP_HUMAN | KNSTRN | physical | 28514442 | |
FBW1A_HUMAN | BTRC | physical | 28514442 | |
FBW1B_HUMAN | FBXW11 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-276, AND MASSSPECTROMETRY. | |
"Aurora-C interacts with and phosphorylates the transforming acidiccoiled-coil 1 protein."; Gabillard J.C., Ulisse S., Baldini E., Sorrenti S., Cremet J.Y.,Coccaro C., Prigent C., D'Armiento M., Arlot-Bonnemains Y.; Biochem. Biophys. Res. Commun. 408:647-653(2011). Cited for: SUBCELLULAR LOCATION, INTERACTION WITH AURKC, PHOSPHORYLATION ATSER-228 BY AURKC, AND MUTAGENESIS OF SER-228. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-52; SER-54;SER-55 AND SER-57, AND MASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-533, AND MASSSPECTROMETRY. |